Literature DB >> 32556386

Effects of umbilical cord mesenchymal stem cells loaded with graphene oxide granular lubrication on cytokine levels in animal models of knee osteoarthritis.

Xiao-Dong Wang1, Xiao-Chun Wan1, Ai-Feng Liu2, Rong Li3, Qiang Wei4.   

Abstract

BACKGROUND: The aim of this study was to use umbilical cord mesenchymal stem cells (UCMSCs) loaded with graphene oxide (GO) granular lubricant to treat knee osteoarthritis (KOA) animal models and to analyze their effect on cytokine levels in the articular cavity.
METHODS: Twenty-four New Zealand rabbit models of KOA were established by the modified Hulth and cartilage injury method, and they were assigned to the blank group, the GO group, the UCMSC group, and the GO + UCMSC group, each group containing six animal models. The GO and UCMSC groups were treated by a single intra-articular injection. The treatment was started one month after surgical modeling, and the observation period was eight weeks. The expression levels of nitric oxide (NO), interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α), glycosaminoglycan (GAG), and collagen-II (COL-II) in serum and articular fluid after treatment were compared to analyze the efficacy.
RESULTS: The GO granular lubricant caused no significant improvement in the intra-articular environment of the knee joint, and UCMSCs caused a certain degree of improvement in the inflammatory environment. The improvement results of NO, IL-6, TNF-α, GAG, and COL-II were the best in the GO + UCMSC group, but the improvement results of inflammatory cytokine levels in serum and articular fluid were not consistent, especially the differences in NO, IL-6, and TNF-α were greater.
CONCLUSION: UCMSCs loaded with the GO granular lubricant can reduce the inflammatory level and improve the level of biochemical environment in the articular cavity, and thus promote cartilage repair.

Entities:  

Keywords:  Cartilage; Cytokine; Graphite oxide; Knee osteoarthritis; Umbilical cord mesenchymal stem cell

Year:  2020        PMID: 32556386     DOI: 10.1007/s00264-020-04584-z

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  19 in total

Review 1.  Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis.

Authors:  Cosimo De Bari; Anke J Roelofs
Journal:  Curr Opin Pharmacol       Date:  2018-04-03       Impact factor: 5.547

2.  Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial.

Authors:  Chris Hyunchul Jo; Young Gil Lee; Won Hyoung Shin; Hyang Kim; Jee Won Chai; Eui Cheol Jeong; Ji Eun Kim; Hackjoon Shim; Ji Sun Shin; Il Seob Shin; Jeong Chan Ra; Sohee Oh; Kang Sup Yoon
Journal:  Stem Cells       Date:  2014-05       Impact factor: 6.277

Review 3.  Mesenchymal stem cells injections for knee osteoarthritis: a systematic overview.

Authors:  Dan Xing; Qi Wang; Ziyi Yang; Yunfei Hou; Wei Zhang; Yaolong Chen; Jianhao Lin
Journal:  Rheumatol Int       Date:  2017-12-22       Impact factor: 2.631

4.  The offspring of people with a total knee replacement for severe primary knee osteoarthritis have a higher risk of worsening knee pain over 8 years.

Authors:  Feng Pan; Changhai Ding; Tania Winzenberg; Hussain Khan; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Flavia Cicuttini; Graeme Jones
Journal:  Ann Rheum Dis       Date:  2014-12-04       Impact factor: 19.103

Review 5.  Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration.

Authors:  Stephen M Richardson; Gauthaman Kalamegam; Peter N Pushparaj; Csaba Matta; Adnan Memic; Ali Khademhosseini; Reza Mobasheri; Fabian L Poletti; Judith A Hoyland; Ali Mobasheri
Journal:  Methods       Date:  2015-09-15       Impact factor: 3.608

Review 6.  Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell.

Authors:  Andreia S Bernardo; Colin W Hay; Kevin Docherty
Journal:  Mol Cell Endocrinol       Date:  2008-07-22       Impact factor: 4.102

7.  OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.

Authors:  Laure Gossec; Gillian Hawker; Aileen M Davis; Jean Francis Maillefert; L Stefan Lohmander; Roy Altman; Jolanda Cibere; Philip G Conaghan; Marc C Hochberg; Joanne M Jordan; Jeffrey N Katz; Lyn March; Nizar Mahomed; Karel Pavelka; Ewa M Roos; Maria E Suarez-Almazor; Gustavo Zanoli; Maxime Dougados
Journal:  J Rheumatol       Date:  2007-06       Impact factor: 4.666

8.  Possible Involvement of Serum and Synovial Fluid Resistin in Knee Osteoarthritis: Cartilage Damage, Clinical, and Radiological Links.

Authors:  Yong-Zhou Song; Jian Guan; Hua-Jun Wang; Wei Ma; Feng Li; Fang Xu; Luo-Bin Ding; Lei Xie; Bo Liu; Kai Liu; Zhe Lv
Journal:  J Clin Lab Anal       Date:  2015-10-23       Impact factor: 2.352

9.  Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation.

Authors:  Antony J Cutler; Vasanti Limbani; John Girdlestone; Cristina V Navarrete
Journal:  J Immunol       Date:  2010-10-27       Impact factor: 5.422

Review 10.  Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis.

Authors:  Ashish R Sharma; Supriya Jagga; Sang-Soo Lee; Ju-Suk Nam
Journal:  Int J Mol Sci       Date:  2013-09-30       Impact factor: 5.923

View more
  6 in total

1.  Intra-articular Injection of Mesenchymal Stem Cells after High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial.

Authors:  Jun-Ho Kim; Kang-Il Kim; Wan Keun Yoon; Sang-Jun Song; Wook Jin
Journal:  Stem Cells Transl Med       Date:  2022-06-08       Impact factor: 7.655

2.  Mesenchymal Stem Cell Therapy for Osteoarthritis: Practice and Possible Promises.

Authors:  Nahid Nasiri; Reihaneh Nateghi; Fatemeh Zarei; Samaneh Hosseini; Mohamdreza Baghaban Eslaminejad
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  Advances in Use of Nanomaterials for Musculoskeletal Regeneration.

Authors:  Josef Jampilek; Daniela Placha
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.321

Review 4.  Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.

Authors:  Alexander Markov; Lakshmi Thangavelu; Surendar Aravindhan; Angelina Olegovna Zekiy; Mostafa Jarahian; Max Stanley Chartrand; Yashwant Pathak; Faroogh Marofi; Somayeh Shamlou; Ali Hassanzadeh
Journal:  Stem Cell Res Ther       Date:  2021-03-18       Impact factor: 6.832

5.  Intra-Articular Injection of Umbilical Cord Mesenchymal Stem Cells Loaded With Graphene Oxide Granular Lubrication Ameliorates Inflammatory Responses and Osteoporosis of the Subchondral Bone in Rabbits of Modified Papain-Induced Osteoarthritis.

Authors:  Aifeng Liu; Jixin Chen; Juntao Zhang; Chao Zhang; Qinxin Zhou; Puyu Niu; Ye Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-14       Impact factor: 5.555

Review 6.  Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications.

Authors:  E Russo; M Caprnda; P Kruzliak; P G Conaldi; C V Borlongan; G La Rocca
Journal:  Stem Cells Int       Date:  2022-01-06       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.